Drug giant to axe jobs in cost-cutting measure

Job losses at pharmaceutical giant GlaxoSmithKline were confirmed today as the group announced plans to ramp up cost savings by £1bn (€1.1bn).

The firm did not reveal how many jobs would be cut from its 100,000-strong global workforce or the impact on UK and Irish staff.